Avidity Biosciences
95 hedge funds and large institutions have $853M invested in Avidity Biosciences in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
95
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$19.3M | |
| 2 | +$8.31M | |
| 3 | +$4.21M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.86M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.74M |
Top Sellers
| 1 | -$5.83M | |
| 2 | -$5.41M | |
| 3 | -$4.46M | |
| 4 |
Goldman Sachs
New York
|
-$4.23M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$2.38M |